CALCULATE YOUR SIP RETURNS

Accretion Pharmaceuticals IPO Set To Open For Subscription On May 14

Written by: Team Angel OneUpdated on: May 9, 2025, 3:06 PM IST
Accretion Pharmaceuticals Limited is set to launch an Initial Public Offering(IPO) from 14-16 May 2025. The issue amount totals to ₹29.75 crores.
Accretion Pharmaceuticals IPO Set To Open For Subscription On May 14
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Accretion Pharmaceuticals Limited, incorporated in 2012, operates in the pharmaceutical sector, specialising in the manufacturing of a broad range of healthcare products. Its portfolio includes tablets, capsules, oral liquids, medicated shampoos, external preparations such as ointments and creams, and oral powders. The company also offers contract manufacturing services and has established itself as a growing player in the healthcare manufacturing space.

IPO Details and Subscription Information

Accretion Pharmaceuticals is launching an Initial Public Offering (IPO) through a book-building process, amounting to ₹29.75 crore. This issue is comprised entirely of a fresh issue totalling 29.46 lakh equity shares. The IPO opens for subscription on 14 May 2025 and closes on 16 May 2025. The allotment is expected to be finalised on 19 May 2025, and the shares are proposed to be listed on the NSE SME platform on 21 May 2025.

 

The IPO price band has been fixed between ₹96 and ₹101 per share. Retail investors can apply for a minimum of one lot, equivalent to 1,200 shares, requiring an investment of ₹1,15,200. However, to strengthen chances of allotment, applying at the cutoff price is suggested, raising the investment to ₹1,21,200. High Net-Worth Individuals (HNIs) must apply for a minimum of two lots (2,400 shares), amounting to ₹2,42,400.

 

Jawa Capital Services Private Limited is acting as the Book Running Lead Manager, and Kfin Technologies Limited is the registrar. Gretex Share Broking Private Limited is the market maker for the IPO.

Company Background and Business Model

Founded in 2012, Accretion Pharmaceuticals has built a robust manufacturing base covering solid, liquid, and semi-solid dosage forms. The company supplies the domestic market and undertakes contract manufacturing for third parties.

 

Its product lines include oral tablets and capsules, syrups, creams, gels, medicated shampoos, powders, and mouthwashes. With an emphasis on quality and affordability, the company aims to strengthen its market presence and operational scale, supported by strategic capital deployment through the IPO.

Objectives of the Issue

 

Sr No.ObjectivesExpected Amount(in Millions)
1Capital expenditure towards the purchase of new equipment/machinery, etc.26.97
2Capital expenditure towards the upgradation of the existing manufacturing facility46.56
3Repayment/prepayment of certain borrowings availed by the Company9.92
4Funding Working Capital Requirements 146.80
5General Corporate PurposesRest Amount

 

Read More: Mouri Tech Limited Re-Files DRHP with SEBI for ₹1,500 Crore IPO

May 08, 2025

Conclusion

The IPO marks a pivotal moment in Accretion Pharmaceuticals’ journey. With clear plans for expansion, debt management, and improved liquidity, the company is positioning itself for sustainable growth. Investors participating in this SME IPO will be supporting a firm with both operational strength and growth potential.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.


 

Published on: May 9, 2025, 3:06 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers